Press & News

People are different and so is their cancer, patients should be treated individually.

Redeye research interview with 2cureX CEO, Fernando Andreu

May 5, 2022


After the publication of the Annual Report 2021, Redeye’s Equity Research Analyst Eric Nordström interviews 2cureX CEO Fernando Andreu about the development of the company in 2021 and the expectations for 2022.

The interview can be accessed here